We are live on !
Find out more
Aster Capital Management Portfolio holdings
AUM
$275M
Turnover
72.56%
1-Year Est. Return
18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
(-41%)
Cap. Flow
-$180M
Cap. Flow % of AUM
Cap. Flow %
-65.37%
Top 10 Holdings %
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$4.57M |
| 2 |
Ovintiv
OVV
|
+$3.99M |
| 3 |
Kimco Realty
KIM
|
+$3.52M |
| 4 |
Astera Labs
ALAB
|
+$3.33M |
| 5 |
Hut 8
HUT
|
+$2.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$11.3M |
| 2 |
Apple
AAPL
|
+$7.75M |
| 3 |
Microsoft
MSFT
|
+$6.82M |
| 4 |
Honeywell
HON
|
+$6.34M |
| 5 |
Coca-Cola
KO
|
+$5.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.08% |
| 2 | Technology | 15.72% |
| 3 | Industrials | 13.9% |
| 4 | Healthcare | 13.43% |
| 5 | Consumer Discretionary | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Amphenol
APH
$193B
| $518K | 0.19% |
6,147
-445
| -7% | -$35.8K |
2025 Q3
4 quarters
|
|
177
Kilroy Realty
KRC
$4.19B
| $510K | 0.19% |
15,339
+486
| +3% | +$18K |
2026 Q2
1 quarter
|
|
178
Thor Industries
THO
$3.99B
| $510K | 0.19% |
7,374
+4,184
| +131% | +$315K |
2026 Q2
1 quarter
|
|
179
Agilent Technologies
A
$49B
| $507K | 0.18% |
+2,943
| New | +$433K |
2026 Q3
0 quarters
|
|
180
Doximity
DOCS
$5.95B
| $506K | 0.18% |
17,846
+10,848
| +155% | +$262K |
2026 Q1
2 quarters
|
|
181
Best Buy
BBY
$21.8B
| $503K | 0.18% |
+5,697
| New | +$491K |
2026 Q3
0 quarters
|
|
182
Kroger
KR
$41.8B
| $502K | 0.18% |
+8,572
| New | +$499K |
2026 Q3
0 quarters
|
|
183
Pagaya Technologies
PGY
$1.42B
| $493K | 0.18% |
28,459
-35,262
| -55% | -$696K |
2025 Q3
4 quarters
|
|
184
Louisiana-Pacific
LPX
$5.3B
| $489K | 0.18% |
7,574
+7,407
| +4,435% | +$530K |
2024 Q3
8 quarters
|
|
185
Cincinnati Financial
CINF
$29.1B
| $488K | 0.18% |
3,062
+2,118
| +224% | +$369K |
2026 Q2
1 quarter
|
|
186
Diamondback Energy
FANG
$51.6B
| $487K | 0.18% |
+2,649
| New | +$518K |
2026 Q3
0 quarters
|
|
187
PPL Corp
PPL
$26.9B
| $486K | 0.18% |
+14,772
| New | +$515K |
2026 Q3
0 quarters
|
|
188
Cooper Companies
COO
$11.9B
| $485K | 0.18% |
8,585
+4,008
| +88% | +$274K |
2026 Q1
2 quarters
|
|
189
Dillards
DDS
$9.7B
| $480K | 0.17% |
716
-611
| -46% | -$370K |
2024 Q4
7 quarters
|
|
190
Lockheed Martin
LMT
$138B
| $477K | 0.17% |
937
+443
| +90% | +$244K |
2025 Q4
3 quarters
|
|
191
Healthpeak Properties
DOC
$13.8B
| $477K | 0.17% |
23,881
+22,409
| +1,522% | +$476K |
2026 Q2
1 quarter
|
|
192
Chord Energy
CHRD
$7.97B
| $467K | 0.17% |
3,486
-10,176
| -74% | -$1.39M |
2026 Q2
1 quarter
|
|
193
Builders FirstSource
BLDR
$6.53B
| $465K | 0.17% |
8,160
+3,292
| +68% | +$226K |
2026 Q1
2 quarters
|
|
194
Brookfield Asset Management
BAM
$82.3B
| $464K | 0.17% |
10,400
+4,010
| +63% | +$196K |
2025 Q4
3 quarters
|
|
195
Morgan Stanley
MS
$298B
| $461K | 0.17% |
2,450
-2,719
| -53% | -$578K |
2026 Q2
1 quarter
|
|
196
Westlake Corp
WLK
$8.13B
| $460K | 0.17% |
+7,380
| New | +$547K |
2026 Q3
0 quarters
|
|
197
FirstEnergy
FE
$27.2B
| $458K | 0.17% |
+10,570
| New | +$496K |
2026 Q3
0 quarters
|
|
198
Caris Life Sciences
CAI
$6.61B
| $457K | 0.17% |
14,915
+5,861
| +65% | +$132K |
2026 Q2
1 quarter
|
|
199
Synchrony
SYF
$22.5B
| $454K | 0.17% |
+6,399
| New | +$487K |
2026 Q3
0 quarters
|
|
200
Comfort Systems
FIX
$38.9B
| $452K | 0.16% |
273
-561
| -67% | -$942K |
2025 Q4
3 quarters
|
|
Similar funds
SL
CP
MEPT
Aster Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.
- Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
- Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
- Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
- Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
- Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
- Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
- Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.